Come up with a name for your new list and we'll add to it:
Xencor raised a round of funding on June 19, 2001. Investors include
National Science Foundation.
Xencor engineers biotherapeutics using its Protein Design Automation technology platform, and is a provider in the field of antibody engineering to significantly improve antibody half-life, immune-reg…